P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

It remains unknown whether the recent trend of short dual antiplatelet therapy (DAPT) followed by P2Y12 inhibitor monotherapy can simply be applied to patients undergoing complex percutaneous coronary intervention (PCI). We performed a systematic review and meta-analysis to evaluate P2Y12 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sotomi, Yohei, Matsuoka, Yuki, Hikoso, Shungo, Nakatani, Daisaku, Okada, Katsuki, Dohi, Tomoharu, Kida, Hirota, Oeun, Bolrathanak, Sunaga, Akihiro, Sato, Taiki, Kitamura, Tetsuhisa, Sakata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400615/
https://www.ncbi.nlm.nih.gov/pubmed/37537330
http://dx.doi.org/10.1038/s41598-023-39213-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400615/
https://www.ncbi.nlm.nih.gov/pubmed/37537330
http://dx.doi.org/10.1038/s41598-023-39213-3

Ejemplares similares